Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
30,210,911
-
Number of holders
-
162
-
Total 13F shares, excl. options
-
17,228,107
-
Shares change
-
+914,837
-
Total reported value, excl. options
-
$389,318,961
-
Value change
-
+$21,532,521
-
Put/Call ratio
-
0%
-
Number of buys
-
73
-
Number of sells
-
-75
-
Price
-
$22.60
Significant Holders of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) as of Q3 2025
191 filings reported holding FLGT - Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2025.
Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) has 162 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17,228,107 shares
of 30,210,911 outstanding shares and own 57% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (2,975,411 shares), MILLENNIUM MANAGEMENT LLC (1,468,844 shares), VANGUARD GROUP INC (1,179,254 shares), ACADIAN ASSET MANAGEMENT LLC (1,140,163 shares), DIMENSIONAL FUND ADVISORS LP (1,133,103 shares), D. E. Shaw & Co., Inc. (567,770 shares), DEUTSCHE BANK AG\ (504,485 shares), STATE STREET CORP (501,996 shares), GEODE CAPITAL MANAGEMENT, LLC (501,671 shares), and AMERIPRISE FINANCIAL INC (494,953 shares).
This table shows the top 162 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.